Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling
Pharmacoeconomics
.
2024 Jul;42(7):715-719.
doi: 10.1007/s40273-024-01364-0.
Epub 2024 Mar 18.
Authors
Isaac Corro Ramos
1
,
Talitha Feenstra
2
3
,
Salah Ghabri
4
,
Maiwenn Al
5
Affiliations
1
Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands. corroramos@imta.eur.nl.
2
Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.
3
Center for Public Health, Health Services and Society, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
4
Department of Medical Evaluation, Direction of Evaluation and Access to Innovation, French National Authority for Health, HAS, Saint-Denis, France.
5
Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
PMID:
38498106
PMCID:
PMC11180005
DOI:
10.1007/s40273-024-01364-0
No abstract available
Publication types
Editorial
MeSH terms
Cost-Benefit Analysis
Economics, Medical
Humans
Models, Economic*
Reproducibility of Results